Annotations
Disease Ontology
central nervous system disease (DOID:331)
A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system.
Table Filters
- Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition - WP4914 (Homo sapiens)
- Alzheimer's disease - WP2075 (Mus musculus)
- Alzheimer's disease - WP5124 (Homo sapiens)
- Alzheimer's disease and miRNA effects - WP2059 (Homo sapiens)
- Amyotrophic lateral sclerosis (ALS) - WP2447 (Homo sapiens)
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
- Chronic hyperglycemia impairment of neuron function - WP5283 (Homo sapiens)
- Ciliopathies - WP4803 (Homo sapiens)
- Copper metabolism - WP5189 (Homo sapiens)
- Corticotropin-releasing hormone - WP3265 (Bos taurus)
- Corticotropin-releasing hormone signaling pathway - WP2355 (Homo sapiens)
- DYRK1A involvement regarding cell proliferation in brain development - WP5180 (Homo sapiens)
- Differentiation pathway - WP3223 (Bos taurus)
- ERK pathway in Huntington's disease - WP3853 (Homo sapiens)
- ErbB signaling pathway - WP1261 (Mus musculus)
- ErbB signaling pathway - WP1299 (Rattus norvegicus)
- ErbB signaling pathway - WP673 (Homo sapiens)
- Ferroptosis - WP4313 (Homo sapiens)
- Glioblastoma signaling pathways - WP2261 (Homo sapiens)
- Involvement of δ-secretase in neurodegenerative diseases - WP5372 (Homo sapiens)
- Iron metabolism disorders - WP5172 (Homo sapiens)
- Joubert syndrome - WP4656 (Homo sapiens)
- KCNQ2-related epilepsies - WP5360 (Homo sapiens)
- Metabolic epileptic disorders - WP5355 (Homo sapiens)
- Mitochondrial complex I inhibition leading to parkinsonian motor deficits - WP4945 (Homo sapiens)
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids - WP5192 (Homo sapiens)
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577 (Homo sapiens)
- Neurotransmitter disorders - WP4220 (Homo sapiens)
- PKC-gamma calcium signaling pathway in ataxia - WP4760 (Homo sapiens)
- Parkinson's disease - WP3638 (Mus musculus)
- Parkinson's disease pathway - WP2371 (Homo sapiens)
- Phosphodiesterases in neuronal function - WP4222 (Homo sapiens)
- Pilocytic astrocytoma - WP2253 (Homo sapiens)
- Pluripotent stem cell differentiation pathway - WP2848 (Homo sapiens)
- Prion disease pathway - WP3995 (Homo sapiens)
- Pro-survival signaling of neuroprotectin D1 - WP5182 (Homo sapiens)
- Spinal cord injury - WP2431 (Homo sapiens)
- Spinal cord injury - WP2432 (Mus musculus)
- Spinal cord injury - WP2433 (Rattus norvegicus)
- Spinal cord injury - WP3186 (Bos taurus)
- TYROBP causal network in microglia - WP3945 (Homo sapiens)
- Valproic acid pathway - WP3871 (Homo sapiens)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- mBDNF and proBDNF regulation of GABA neurotransmission - WP4829 (Homo sapiens)